Sort
16,300 grants matching “fatty liver disease”
Elucidating the consequences of dietary sugar consumption on the gut microbiota
$506,330Guy Edmund Townsend · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · DK
Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLD
$506,326David E Cohen · Brigham And Women'S Hospital · R01 · FY2022 · DK
Mini-Livers Derived from Human IPS Cells for Modeling Steatosis and Therapy
$506,236Alejandro Soto-Gutierrez · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Targeting the orphan nuclear receptor LRH-1 with small molecules
$506,100Eric A Ortlund · Emory University · R01 · FY2019 · DK
Environmental Liver Disease
$506,019Matthew C Cave · University Of Louisville · R35 · FY2020 · ES
Dissecting the NRG4 hormonal checkpoint in metabolic liver disease
$505,838Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2020 · DK
Translational Systems Genetics of Mitochondria, Metabolism, and Aging
$505,811Robert W. W Williams · University Of Tennessee Health Sci Ctr · R01 · FY2016 · AG
Translational Systems Genetics of Mitochondria, Metabolism, and Aging
$505,811Robert W. W Williams · University Of Tennessee Health Sci Ctr · R01 · FY2014 · AG
Long-lived mice and species as test beds for drug and pathway discovery
$505,705Richard A. Miller · California Pacific Med Ctr Res Institute · U19 · FY2019 · AG
Rejuvenating Skeletal Health Through A Novel Brain-Bone Axis
$505,552Holly A. Ingraham · University Of California, San Francisco · U01 · FY2025 · AG
Molecular and Clinical Studies of Insulin Resistance
$505,529Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Clinical utility of leptin therapy in syndromic forms of insulin resistance.
$505,529Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Administrative
$505,521Michael W Schwartz · University Of Washington · P30 · FY2016 · DK
Transcriptional and metabolic regulation of Treg cell specification for the control of allergic airway disease
$505,502Kai Yang · Indiana University Indianapolis · R01 · FY2023 · AI
Imaging Hepatic Energy Metabolism in NAFLD/NASH
$505,490Matthew E Merritt · University Of Florida · R01 · FY2022 · DK
Zeiss LSM 900 with Airyscan 2
$505,388Lori M Zeltser · Columbia University Health Sciences · S10 · FY2024 · OD
Intra-abdominal fat and risk of disease in adolescents
$505,387Michael I Goran · University Of Southern California · R01 · FY2008 · HD
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles
$505,331Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2020 · ES
Viral mechanisms of adipocyte dysfuntion: Role of Vpr.
$505,325Ashok Balasubramanyam · Baylor College Of Medicine · R01 · FY2010 · DK
Transforming Growth Factor - Beta Superfamily Signaling in Diabetes and Obesity
$505,316Sushil Rane · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Long-lived mice and species as test beds for drug and pathway discovery
$505,220Richard A. Miller · California Pacific Med Ctr Res Institute · U19 · FY2020 · AG
Role of estrogen receptor-a in aging and sex-specific responses to 17a-estradiol
$505,160Michael B Stout · Oklahoma Medical Research Foundation · R01 · FY2025 · AG
Using resistance training to reduce metabolic and cardiovascular disease risk in
$505,156Christian Roberts · University Of Southern California · P60 · FY2008 · MD
Hyperinsulinemia and the pathogenesis of NASH
$504,988Saint Louis University · U01 · FY2005 · DK
TREAT-VCU
$504,933Arun J Sanyal · Virginia Commonwealth University · U01 · FY2014 · AA